Barney S Graham

This inventor holds 47 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Dartmouth College, Vanderbilt University. Active years: 2000-2026.

USPTO Granted Patents = 47 (Patent Applications = 20)

% Patents Active = 95.7

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 6 (Patent Applications = 15)

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 130(Granted Patents)

Location History:

Nashville, TN (US) (2000 - 2004)
Rockville, MD (US) (2006 - 2024)
Bethesda, MD (US) (2018 - 2024)
Smyrna, GA (US) (2023 - 2024)

Company Filing History:

45 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Vanderbilt University

patents

4. 2 out of 2

Abcellera Biologies Inc.

Institute for Research in Biomedicine

patents

7. 2 out of 1,204

Scripps Research Institute

US Government as Represented by the Secretary of the Army

patents

10. 1 out of 2

Abcellera Biologics Inc.

patents

11. 1 out of 545

Glaxosmithkline Biologicals Sa

patents

12. 1 out of 7

Korea Center for Disease Control and Prevention

patents

13. 1 out of 2,166

University of Washington

Xiamen Innovax Biotech Co., Ltd.

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Influenza Vaccines

RSV Proteins

Coronavirus Antibodies

Nanoparticle Vaccines

Monoclonal Antibodies

Immunogens

Prefusion Proteins

Zika Virus

Self-Assembling Nanoparticles

Hemagglutinin Trimers

Neutralizing Antibodies

Viral Antigens

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661322 - NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES (2026-06-23),

2. 12643925 - RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF (2026-06-02),

3. 12636360 - MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE (2026-05-26),

4. 12527857 - STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF (2026-01-20),

5. 12433943 - Nanoparticle-based influenza virus vaccines and uses thereof (2025-10-07),

6. 12275758 - Prefusion RSV F proteins and their use (2025-04-14),

7. 12268737 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2025-04-08),

8. 12172038 - Anti-coronavirus antibodies and methods of use (2024-12-24),

9. 12077572 - Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof (2024-09-03),

10. 12018051 - Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof (2024-06-25),

11. 11981707 - Prefusion RSV F proteins and their use (2024-05-14),

12. 11969466 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2024-04-30),

13. 11964010 - Prefusion coronavirus spike proteins and their use (2024-04-23),

14. 11939356 - Self-assembling insect ferritin nanoparticles (2024-03-26),

15. 11938221 - Multivalent nanoparticle-based vaccines (2024-03-26),

Title: The Pioneering Inventor: Barney S. Graham

Introduction:

Barney S. Graham, a visionary inventor based in Rockville, MD (US), has made significant contributions to the field of biotechnology and public health. With a total of 28 patents to his name, Graham's innovative spirit and dedication to scientific excellence have propelled him to the forefront of vaccine development and research.

Latest Patents:

Graham's recent patents include groundbreaking work on "Multivalent nanoparticle-based vaccines" and "Prefusion RSV F proteins and their use." These innovations focus on developing novel nanoparticle-based vaccines that induce a broad immune response to various infectious agents, such as influenza viruses and Respiratory Syncytial Virus (RSV).

Career Highlights:

Throughout his illustrious career, Graham has worked with prestigious institutions such as the United States of America, represented by the Department of Health and Human Services, and Vanderbilt University. His pioneering research has not only advanced the field of biotechnology but has also paved the way for transformative solutions to global health challenges.

Collaborations:

Graham has collaborated with esteemed experts in the field, including Masaru Kanekiyo and Peter D. Kwong. These collaborations have led to the development of innovative vaccines and therapeutics that have the potential to revolutionize the prevention and treatment of infectious diseases.

Conclusion:

In conclusion, Barney S. Graham's impact as an inventor and researcher is truly remarkable. His patented inventions in the realm of vaccine development reflect his unwavering commitment to advancing public health and tackling pressing global challenges. Graham's legacy as a pioneering inventor continues to inspire future generations of researchers and inventors to push the boundaries of scientific innovation.